Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference20 articles.
1. Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer;Saxman;Invest New Drugs,1991
2. Chronic oral etoposide in non-small cell lung carcinoma;Estape;Eur J Cancer,1992
3. Prolonged administration of oral etoposide in non-small-cell-lung cancer: a phase II trial;Waits;J Clin Oncol,1992
4. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer;Fukuoka;Cancer,1991
5. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B;Miller;J Clin Oncol,1995
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemotherapy for Advanced and Recurrent Cervical Cancer;Comprehensive Gynecology and Obstetrics;2024
2. Systemic therapy for advanced cervical cancer: Leveraging the historical threshold of overall survival;Critical Reviews in Oncology/Hematology;2023-03
3. Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer;Holland‐Frei Cancer Medicine;2022-10-21
4. Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial;Frontiers in Oncology;2021-11-02
5. Pharmacological Treatment of Patients with Metastatic, Recurrent or Persistent Cervical Cancer Not Amenable by Surgery or Radiotherapy: State of Art and Perspectives of Clinical Research;Cancers;2020-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3